Pub Date : 2026-01-01Epub Date: 2025-12-08DOI: 10.1007/s13205-025-04649-z
L F A Anand Raj, S Shreya, G Rithika, S Karthick Raja Namasivayam, G P Avinash
Metallic nanoparticles synthesized from plants have recently attracted significant attention in biomedical research. In this study, highly stable zinc oxide nanoparticles (ZnO NPs) were fabricated using the aqueous seed extract of Myristica fragrans (nutmeg) and evaluated for their anticancer, antibacterial, and anti-inflammatory activities. The biocompatibility and therapeutic safety of the synthesized ZnO NPs were assessed using non-cancerous Vero cells. Adopting green synthesis principles resulted in the formation of highly stable, spherical ZnO nanoparticles ranging from 50 to 120 nm in size, capped with phytochemical constituents from M. fragrans and exhibiting high crystallinity. The anticancer potential of the synthesized nanoparticles was investigated in HeLa cervical cancer cells by assessing cell viability (MTT assay), alterations in antioxidant enzyme levels (CAT and SOD), and reactive oxygen species (ROS) generation. Additionally, in silico molecular docking was performed to further elucidate the observed anticancer effects. The ZnO NPs demonstrated potent anticancer activity against HeLa cells, as evidenced by reduced cell viability, modulation of antioxidant enzymes, and enhanced ROS production. In silico docking analysis supported these findings, revealing strong binding affinities between key bioactive compounds from the seed extract-macelignan and malabaricone C-and target proteins such as the E6 oncoprotein and the vertebrate RNA-binding domain of telomerase. The synthesized ZnO NPs also exhibited notable antibacterial efficacy, inhibiting the growth of Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa at relatively low concentrations. Furthermore, their anti-inflammatory potential was confirmed through protein denaturation inhibition and stabilization of human red blood cell (HRBC) membranes in the HRBC membrane stabilization assay. Importantly, the ZnO NPs showed high biocompatibility, as indicated by the absence of cytotoxic effects on Vero cells.The findings suggest that ZnO nanoparticles synthesized from Myristica fragrans seed extract may serve as multifunctional bioactive agents with promising anticancer, antibacterial, and anti-inflammatory properties, along with notable biosafety and biocompatibility.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04649-z.
{"title":"Multi-functional zinc oxide nanoparticles (ZnONps inspired from <i>Myristica Fragrans</i> seed extract against cervical Cancer, pyogenic bacteria and inflammatory response. a promising potential of ZnONps in cancer nanotherapy, infection control and inflammation management.","authors":"L F A Anand Raj, S Shreya, G Rithika, S Karthick Raja Namasivayam, G P Avinash","doi":"10.1007/s13205-025-04649-z","DOIUrl":"https://doi.org/10.1007/s13205-025-04649-z","url":null,"abstract":"<p><p>Metallic nanoparticles synthesized from plants have recently attracted significant attention in biomedical research. In this study, highly stable zinc oxide nanoparticles (ZnO NPs) were fabricated using the aqueous seed extract of <i>Myristica fragrans</i> (nutmeg) and evaluated for their anticancer, antibacterial, and anti-inflammatory activities. The biocompatibility and therapeutic safety of the synthesized ZnO NPs were assessed using non-cancerous Vero cells. Adopting green synthesis principles resulted in the formation of highly stable, spherical ZnO nanoparticles ranging from 50 to 120 nm in size, capped with phytochemical constituents from <i>M. fragrans</i> and exhibiting high crystallinity. The anticancer potential of the synthesized nanoparticles was investigated in HeLa cervical cancer cells by assessing cell viability (MTT assay), alterations in antioxidant enzyme levels (CAT and SOD), and reactive oxygen species (ROS) generation. Additionally, in silico molecular docking was performed to further elucidate the observed anticancer effects. The ZnO NPs demonstrated potent anticancer activity against HeLa cells, as evidenced by reduced cell viability, modulation of antioxidant enzymes, and enhanced ROS production. In silico docking analysis supported these findings, revealing strong binding affinities between key bioactive compounds from the seed extract-macelignan and malabaricone C-and target proteins such as the E6 oncoprotein and the vertebrate RNA-binding domain of telomerase. The synthesized ZnO NPs also exhibited notable antibacterial efficacy, inhibiting the growth of <i>Staphylococcus aureus</i>, <i>Escherichia coli</i>, <i>Enterococcus faecalis</i>, and <i>Pseudomonas aeruginosa</i> at relatively low concentrations. Furthermore, their anti-inflammatory potential was confirmed through protein denaturation inhibition and stabilization of human red blood cell (HRBC) membranes in the HRBC membrane stabilization assay. Importantly, the ZnO NPs showed high biocompatibility, as indicated by the absence of cytotoxic effects on Vero cells.The findings suggest that ZnO nanoparticles synthesized from <i>Myristica fragrans</i> seed extract may serve as multifunctional bioactive agents with promising anticancer, antibacterial, and anti-inflammatory properties, along with notable biosafety and biocompatibility.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04649-z.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"21"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12686306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-29DOI: 10.1007/s13205-025-04644-4
Arif Jamal Siddiqui, Ahmed Mohajja Alshammari, Mitesh Patel, Ahmed Eisa Mahmoud Ghoniem, Hemlata Dwivedi-Agnihotri, Noor Ziad Suliman AlBo'ul, Sadaf Jahan, Riadh Badraoui, Mohd Adnan
The present study elucidates the anticancer potential of Andrographis paniculata against breast cancer through an integrative approach combining network pharmacology, molecular docking, molecular dynamics simulations and in-vitro assays. A total of 14 bioactive compounds and 215 potential therapeutic targets were identified, revealing key interactions with major signaling pathways, including PI3K-Akt, JAK-STAT and estrogen signaling. Among these, daucosterol, andrographidine C and apigenin demonstrated the strongest binding affinities and structural stability with core proteins AKT1, EGFR and STAT3. Molecular dynamics simulations confirmed the stability of these ligand-protein complexes over a 100 ns period. In-vitro validation using MCF-7 breast cancer cells showed a dose-dependent cytotoxic effect (IC50 = 93.8 µg/mL), increased apoptosis and G1 phase cell cycle arrest. Collectively, these results reveal that A. paniculata exerts a multi-targeted anticancer effect by modulating apoptosis, proliferation and angiogenic signaling, providing a mechanistic foundation for its potential development as a natural therapeutic agent for breast cancer treatment.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04644-4.
{"title":"Deciphering the anti-cancer potential of <i>Andrographis paniculata</i> (Burm.f.) Nees (Acanthaceae) against breast Cancer: insights from network pharmacology and in-vitro studies.","authors":"Arif Jamal Siddiqui, Ahmed Mohajja Alshammari, Mitesh Patel, Ahmed Eisa Mahmoud Ghoniem, Hemlata Dwivedi-Agnihotri, Noor Ziad Suliman AlBo'ul, Sadaf Jahan, Riadh Badraoui, Mohd Adnan","doi":"10.1007/s13205-025-04644-4","DOIUrl":"https://doi.org/10.1007/s13205-025-04644-4","url":null,"abstract":"<p><p>The present study elucidates the anticancer potential of <i>Andrographis paniculata</i> against breast cancer through an integrative approach combining network pharmacology, molecular docking, molecular dynamics simulations and in-vitro assays. A total of 14 bioactive compounds and 215 potential therapeutic targets were identified, revealing key interactions with major signaling pathways, including PI3K-Akt, JAK-STAT and estrogen signaling. Among these, daucosterol, andrographidine C and apigenin demonstrated the strongest binding affinities and structural stability with core proteins AKT1, EGFR and STAT3. Molecular dynamics simulations confirmed the stability of these ligand-protein complexes over a 100 ns period. In-vitro validation using MCF-7 breast cancer cells showed a dose-dependent cytotoxic effect (IC<sub>50</sub> = 93.8 µg/mL), increased apoptosis and G1 phase cell cycle arrest. Collectively, these results reveal that <i>A. paniculata</i> exerts a multi-targeted anticancer effect by modulating apoptosis, proliferation and angiogenic signaling, providing a mechanistic foundation for its potential development as a natural therapeutic agent for breast cancer treatment.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04644-4.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"41"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145861723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-05DOI: 10.1007/s13205-025-04663-1
Jian Feng, Zhiwei Yan, Jinfeng Ge
Cell division cycle 25 A (CDC25A) is a key regulatory molecule of the cell cycle. However, the expression of CDC25A and its importance in esophageal cancer remain unclear. In this study, we found that CDC25A was highly expressed in esophageal cancer tissues utilizing the Cancer Genome Atlas (TCGA) database, Western blot, immunohistochemistry, and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). By detecting cell proliferation, migration, invasion and apoptosis, it was observed that knockdown of CDC25A inhibited cell proliferation, migration and invasion and promoted apoptosis. By screening for deubiquitinating enzymes, ubiquitin-specific peptidase 1 (USP1) was identified as a deubiquitinating enzyme that bound to, deubiquitinated and stabilized the CDC25A protein. We also showed that CDC25A targeted cyclin-dependent kinase 1 (CDK1) to promote cell proliferation. Furthermore, USP1 knockdown suppressed xenografted tumor growth in nude mice, whereas overexpression of CDK1 promoted tumor growth. In conclusion, our findings suggest that the USP1/CDC25A/CDK1 axis influences esophageal carcinogenesis and progression.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04663-1.
{"title":"USP1 regulates esophageal cancer progression through CDC25A deubiquitination to regulate CDK1 expression.","authors":"Jian Feng, Zhiwei Yan, Jinfeng Ge","doi":"10.1007/s13205-025-04663-1","DOIUrl":"https://doi.org/10.1007/s13205-025-04663-1","url":null,"abstract":"<p><p>Cell division cycle 25 A (CDC25A) is a key regulatory molecule of the cell cycle. However, the expression of CDC25A and its importance in esophageal cancer remain unclear. In this study, we found that CDC25A was highly expressed in esophageal cancer tissues utilizing the Cancer Genome Atlas (TCGA) database, Western blot, immunohistochemistry, and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). By detecting cell proliferation, migration, invasion and apoptosis, it was observed that knockdown of CDC25A inhibited cell proliferation, migration and invasion and promoted apoptosis. By screening for deubiquitinating enzymes, ubiquitin-specific peptidase 1 (USP1) was identified as a deubiquitinating enzyme that bound to, deubiquitinated and stabilized the CDC25A protein. We also showed that CDC25A targeted cyclin-dependent kinase 1 (CDK1) to promote cell proliferation. Furthermore, USP1 knockdown suppressed xenografted tumor growth in nude mice, whereas overexpression of CDK1 promoted tumor growth. In conclusion, our findings suggest that the USP1/CDC25A/CDK1 axis influences esophageal carcinogenesis and progression.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04663-1.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"47"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-05DOI: 10.1007/s13205-025-04688-6
Karthik Shree Harini, Devaraj Ezhilarasan
This study investigated the cytotoxic property of cardionogen-1 (CDNG-1), a small molecule Wnt/β-catenin signalling inhibitor in the human hepatoma cell line. Huh-7 cells were treated with 5, 10, and 20 µM/ml of CDNG-1 for 24 h. Cytotoxicity assay, intracellular reactive oxygen species (ROS) analysis, apoptotic evaluation, scratch assay, flow cytometry, PCR and western blotting were performed to investigate the anticancer effect of CDNG-1 in Huh-7 cells. CDNG-1 markedly inhibited the viability, proliferation, and migration of Huh-7 cells in a dose-dependent manner. Fluorescence microscopic analyses revealed typical characteristics of ROS-mediated early apoptosis in Huh-7 cells upon CDNG-1 treatment. CDNG-1 effectively induced intrinsic apoptosis in Huh-7 cells, evidenced by increased protein levels of p53, p21, Bax, and cytochrome c, and decreased protein levels of the anti-apoptotic Bcl-2. CDNG-1 disrupted the cell cycle and caused accumulation of Huh-7 cells at the G0/G1, S and G2/M phases. CDNG-1 was also found to reduce the protein expression of cell cycle regulators like cyclin D and CDK-4. Moreover, CDNG-1 inhibited the Wnt/β-catenin pathway, evidenced by downregulated gene expression of Wnt3, LRP6 and β-catenin. Therefore, this study suggests that CDNG-1 exerts potential anti-proliferative, anti-migratory, and pro-apoptotic effects in liver cancer cells in a concentration-dependent manner, and hence, it could serve as a promising anticancer candidate for targeted therapies against liver cancer.
{"title":"Cardionogen-1, a novel small molecule, induces cytotoxicity by inhibiting Wnt/β-catenin signalling pathway in Huh-7 cells.","authors":"Karthik Shree Harini, Devaraj Ezhilarasan","doi":"10.1007/s13205-025-04688-6","DOIUrl":"https://doi.org/10.1007/s13205-025-04688-6","url":null,"abstract":"<p><p>This study investigated the cytotoxic property of cardionogen-1 (CDNG-1), a small molecule Wnt/β-catenin signalling inhibitor in the human hepatoma cell line. Huh-7 cells were treated with 5, 10, and 20 µM/ml of CDNG-1 for 24 h. Cytotoxicity assay, intracellular reactive oxygen species (ROS) analysis, apoptotic evaluation, scratch assay, flow cytometry, PCR and western blotting were performed to investigate the anticancer effect of CDNG-1 in Huh-7 cells. CDNG-1 markedly inhibited the viability, proliferation, and migration of Huh-7 cells in a dose-dependent manner. Fluorescence microscopic analyses revealed typical characteristics of ROS-mediated early apoptosis in Huh-7 cells upon CDNG-1 treatment. CDNG-1 effectively induced intrinsic apoptosis in Huh-7 cells, evidenced by increased protein levels of p53, p21, Bax, and cytochrome c, and decreased protein levels of the anti-apoptotic Bcl-2. CDNG-1 disrupted the cell cycle and caused accumulation of Huh-7 cells at the G<sub>0</sub>/G<sub>1</sub>, S and G<sub>2</sub>/M phases. CDNG-1 was also found to reduce the protein expression of cell cycle regulators like cyclin D and CDK-4. Moreover, CDNG-1 inhibited the Wnt/β-catenin pathway, evidenced by downregulated gene expression of Wnt3, LRP6 and β-catenin. Therefore, this study suggests that CDNG-1 exerts potential anti-proliferative, anti-migratory, and pro-apoptotic effects in liver cancer cells in a concentration-dependent manner, and hence, it could serve as a promising anticancer candidate for targeted therapies against liver cancer.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"57"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-05DOI: 10.1007/s13205-025-04683-x
Khaoula Jedda, Mahmood Al-Hinai, Huda Al Battashi, Raeid M M Abed
Acrylamide degradation, especially by microbial mat microorganisms, remains poorly investigated. This is significant because acrylamide is the toxic monomer of partially hydrolyzed polyacrylamide (HPAM), widely used in enhanced oil recovery (EOR). In this study, microbial mats from a constructed wetland treating oilfield produced water were tested for their ability to tolerate and degrade acrylamide. Respiration assays showed a twofold increase in CO₂ (7%) at 1000 mg/L acrylamide compared to the control, indicating its complete mineralization to CO₂. At 2000 mg/L acrylamide concentration, CO₂ decreased to 2.7% due to toxicity. Acrylamide removal reached ≥ 90% at 500-1000 mg/L, but dropped to 13 ± 5.5% at 2000 mg/L. MiSeq amplicon sequencing revealed increased bacterial richness and enrichment of Gamma- and Alphaproteobacteria after acrylamide degradation. Dominant taxa were Pseudomonas pseudoalcaligenes (41-70% of sequences) and Glycocaulis abyssi (up to 7.8%). Phototrophic cultures (Cyanobacterium stanieri NU2, NU14; Asterarcys quadricellulare RA100) tolerated up to 1000 mg/L. Cyanobacterium stanieri NU14 degraded acrylamide at all tested concentrations (50-1000 mg/L), while Cyanobacterium stanieri NU2 achieved complete removal up to 200 mg/L. Bacterial isolates belonging to Ochrobactrum, Agrobacterium, and Microbacterium grew on acrylamide as a carbon and/or nitrogen source. Ochrobactrum sp. K15 achieved complete acrylamide degradation, and Agrobacterium sp. K16 removed 97 ± 4.5% within 7 days. These findings show that microbial mats, and their associated phototrophic and heterotrophic microorganisms, can efficiently degrade acrylamide over a wide concentration range. They represent a promising bioremediation strategy for produced water.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04683-x.
{"title":"Degradation of acrylamide in oilfield produced water by microbial mat microorganisms.","authors":"Khaoula Jedda, Mahmood Al-Hinai, Huda Al Battashi, Raeid M M Abed","doi":"10.1007/s13205-025-04683-x","DOIUrl":"https://doi.org/10.1007/s13205-025-04683-x","url":null,"abstract":"<p><p>Acrylamide degradation, especially by microbial mat microorganisms, remains poorly investigated. This is significant because acrylamide is the toxic monomer of partially hydrolyzed polyacrylamide (HPAM), widely used in enhanced oil recovery (EOR). In this study, microbial mats from a constructed wetland treating oilfield produced water were tested for their ability to tolerate and degrade acrylamide. Respiration assays showed a twofold increase in CO₂ (7%) at 1000 mg/L acrylamide compared to the control, indicating its complete mineralization to CO₂. At 2000 mg/L acrylamide concentration, CO₂ decreased to 2.7% due to toxicity. Acrylamide removal reached ≥ 90% at 500-1000 mg/L, but dropped to 13 ± 5.5% at 2000 mg/L. MiSeq amplicon sequencing revealed increased bacterial richness and enrichment of Gamma- and Alphaproteobacteria after acrylamide degradation. Dominant taxa were <i>Pseudomonas pseudoalcaligenes</i> (41-70% of sequences) and <i>Glycocaulis abyssi</i> (up to 7.8%). Phototrophic cultures (<i>Cyanobacterium stanieri</i> NU2, NU14; <i>Asterarcys quadricellulare</i> RA100) tolerated up to 1000 mg/L. <i>Cyanobacterium stanieri</i> NU14 degraded acrylamide at all tested concentrations (50-1000 mg/L), while <i>Cyanobacterium stanieri</i> NU2 achieved complete removal up to 200 mg/L. Bacterial isolates belonging to <i>Ochrobactrum</i>, <i>Agrobacterium</i>, and <i>Microbacterium</i> grew on acrylamide as a carbon and/or nitrogen source. <i>Ochrobactrum</i> sp. K15 achieved complete acrylamide degradation, and <i>Agrobacterium</i> sp. K16 removed 97 ± 4.5% within 7 days. These findings show that microbial mats, and their associated phototrophic and heterotrophic microorganisms, can efficiently degrade acrylamide over a wide concentration range. They represent a promising bioremediation strategy for produced water.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04683-x.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"60"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asthma is a chronic inflammatory disorder of the airways, characterized by hyperresponsiveness, airflow obstruction, and recurrent respiratory symptoms. Despite advancements in pharmacological treatments, current therapies often have side effects and show variable effectiveness, underscoring the need for safer and more effective alternatives. Pistacia integerrima J.L. Stewart ex Brandis, commonly known as Kakarsinghi, has traditionally been used in South Asia to treat respiratory conditions, including cough, bronchitis, and asthma. This practice is prevalent in Ayurveda, Unani medicine, and local folklore. Phytochemical studies have identified various bioactive compounds in Kakarsinghi, including flavonoids, terpenoids, and phenolic acids, which exhibit antioxidant, anti-inflammatory, immunomodulatory, and bronchodilatory properties. Preclinical research demonstrates that P. integerrima extracts and isolated constituents can modulate key molecular pathways associated with asthma pathophysiology, including the inhibition of NF-κB, suppression of inducible nitric oxide synthase, modulation of mast cell stabilization, and downregulation of Th2 cytokines such as IL-4, IL-5, and IL-13. Clinical studies indicate that galls may effectively prevent respiratory attacks and enhance chest expansion and respiratory rate when used in poly-herbal formulations. These findings support the traditional use of galls and suggest their potential as an adjunct therapy. This review speculates on the available data, comprising ethnobotany, phytochemistry, pharmacology, and multifaceted therapeutic prospects of P. integerrima, highlighting its potential role as a natural intervention for asthma.
哮喘是一种气道慢性炎症性疾病,以高反应性、气流阻塞和反复出现呼吸道症状为特征。尽管药物治疗取得了进步,但目前的治疗方法往往有副作用,而且效果不一,因此需要更安全、更有效的替代方法。黄连木J.L. Stewart ex Brandis,俗称Kakarsinghi,在南亚传统上用于治疗呼吸系统疾病,包括咳嗽、支气管炎和哮喘。这种做法在阿育吠陀、乌纳尼医学和当地民间传说中很普遍。植物化学研究已经鉴定出kakarsingi中的各种生物活性化合物,包括黄酮类化合物、萜类化合物和酚酸,它们具有抗氧化、抗炎、免疫调节和支气管扩张的特性。临床前研究表明,整枝草提取物和分离成分可以调节哮喘病理生理相关的关键分子通路,包括抑制NF-κB、抑制诱导型一氧化氮合酶、调节肥大细胞稳定性、下调Th2细胞因子如IL-4、IL-5和IL-13。临床研究表明,在多草药配方中使用,可以有效地预防呼吸疾病,增强胸部扩张和呼吸频率。这些发现支持了传统的胆囊疗法,并提示其作为辅助疗法的潜力。这篇综述推测了现有的数据,包括民族植物学,植物化学,药理学和多方面的治疗前景,强调了其作为哮喘自然干预的潜在作用。
{"title":"A multi-faceted pharmacology of <i>Pistacia Integerrima</i> mitigating asthma: a review on ethnopharmacology, phytochemicals, mechanisms, and formulations.","authors":"Aditi Sharma, Md Abubakar, Rashi Yadav, S Sarika, Rohit Sharma, Uma Ranjan Lal, Vijay Kumar Kapoor, Sachchida Nand Rai, Nitesh Kumar, Rohit Goyal","doi":"10.1007/s13205-025-04664-0","DOIUrl":"https://doi.org/10.1007/s13205-025-04664-0","url":null,"abstract":"<p><p>Asthma is a chronic inflammatory disorder of the airways, characterized by hyperresponsiveness, airflow obstruction, and recurrent respiratory symptoms. Despite advancements in pharmacological treatments, current therapies often have side effects and show variable effectiveness, underscoring the need for safer and more effective alternatives. <i>Pistacia integerrima</i> J.L. Stewart ex Brandis, commonly known as Kakarsinghi, has traditionally been used in South Asia to treat respiratory conditions, including cough, bronchitis, and asthma. This practice is prevalent in Ayurveda, Unani medicine, and local folklore. Phytochemical studies have identified various bioactive compounds in Kakarsinghi, including flavonoids, terpenoids, and phenolic acids, which exhibit antioxidant, anti-inflammatory, immunomodulatory, and bronchodilatory properties. Preclinical research demonstrates that <i>P. integerrima</i> extracts and isolated constituents can modulate key molecular pathways associated with asthma pathophysiology, including the inhibition of NF-κB, suppression of inducible nitric oxide synthase, modulation of mast cell stabilization, and downregulation of Th2 cytokines such as IL-4, IL-5, and IL-13. Clinical studies indicate that galls may effectively prevent respiratory attacks and enhance chest expansion and respiratory rate when used in poly-herbal formulations. These findings support the traditional use of galls and suggest their potential as an adjunct therapy. This review speculates on the available data, comprising ethnobotany, phytochemistry, pharmacology, and multifaceted therapeutic prospects of <i>P. integerrima</i>, highlighting its potential role as a natural intervention for asthma.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"61"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-29DOI: 10.1007/s13205-025-04657-z
Eetika Chot, M Vasundhara, Krishna Mohan Medicherla, M Sudhakara Reddy
Taxol (paclitaxel) is a widely used anticancer drug with a complex biosynthetic pathway that has puzzled biochemists for decades. The endophytic fungus Fusarium tricinctum T6 isolated from the bark of Taxus baccata comprises potential anticancer and antioxidant activities. In the present study, the fungal extract profiling using the UHPLC-ESI-MS/MS technique confirmed the Taxol production from F. tricinctum T6 strain. The study further addressed the long-standing challenge of uncovering the fungal Taxol biosynthesis genes and pathway. In genome-wide sequence analysis, among 13,249 predicted gene models, 8 associated with the mevalonate pathway and 19 other Taxol biosynthesis genes were determined, whereas no single 2-C-methyl-D-erythritol 4-phosphate pathway-related gene was found. The identified fungal Taxol biosynthesis genes are mainly homologous to those in Taxus and other plant species, with low percentage identities. Contrary to past studies, the conserved "DXDD" motif was observed in predicted taxa-4(5),11(12)-diene synthase of F. tricinctum and Pestalotiopsis microspora. Notably, despite the low sequence identities between F. tricinctum and Taxus brevifolia taxa-4(5),11(12)-diene synthase, the remarkable structural similarity of their active sites indicates likely conservation of enzymatic function. The study revealed the Taxol production and sole involvement of the mevalonate pathway in the biosynthesis of Taxol precursors, while supporting the potential independent origin of the Taxol biosynthesis pathway in F. tricinctum from the host plants. This work also provides an understanding of Taxol biosynthesis and establishes a foundation for its biotechnological production.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04657-z.
紫杉醇(紫杉醇)是一种广泛应用的抗癌药物,其复杂的生物合成途径困扰了生物化学家几十年。从红豆杉(Taxus baccata)树皮中分离到的内生真菌镰刀菌(Fusarium tricinctum T6)具有潜在的抗癌和抗氧化活性。本研究采用UHPLC-ESI-MS/MS技术对真菌提取物进行分析,证实了F. tricinctum T6菌株产紫杉醇。该研究进一步解决了揭示真菌紫杉醇生物合成基因和途径的长期挑战。在全基因组序列分析中,在13249个预测基因模型中,确定了8个与甲羟戊酸途径相关的基因和19个其他紫杉醇生物合成基因,而没有发现单个2- c -甲基- d -赤藓糖醇4-磷酸途径相关的基因。鉴定的真菌紫杉醇生物合成基因主要与红豆杉属和其他植物同源,同源率较低。与以往的研究相反,在预测的F. tricinctum和拟盘多毛孢(pstalotiopsis microspora)的4(5)、11(12)-二烯合成酶中发现了保守的“DXDD”基序。值得注意的是,尽管三角红豆杉和短叶红豆杉类群-4(5),11(12)-二烯合成酶的序列同源性较低,但其活性位点的显著结构相似性表明可能存在酶功能的保守性。该研究揭示了紫杉醇的产生和甲羟戊酸途径单独参与了紫杉醇前体的生物合成,同时支持了紫杉醇生物合成途径可能来自寄主植物的独立来源。本研究为紫杉醇的生物合成提供了新的认识,并为其生物技术生产奠定了基础。补充信息:在线版本包含补充资料,下载地址:10.1007/s13205-025-04657-z。
{"title":"Taxol production and Elucidation of its biosynthetic pathway in endophytic fungus <i>Fusarium tricinctum</i> associated with <i>Taxus baccata</i>.","authors":"Eetika Chot, M Vasundhara, Krishna Mohan Medicherla, M Sudhakara Reddy","doi":"10.1007/s13205-025-04657-z","DOIUrl":"https://doi.org/10.1007/s13205-025-04657-z","url":null,"abstract":"<p><p>Taxol (paclitaxel) is a widely used anticancer drug with a complex biosynthetic pathway that has puzzled biochemists for decades. The endophytic fungus <i>Fusarium tricinctum</i> T6 isolated from the bark of <i>Taxus baccata</i> comprises potential anticancer and antioxidant activities. In the present study, the fungal extract profiling using the UHPLC-ESI-MS/MS technique confirmed the Taxol production from <i>F. tricinctum</i> T6 strain. The study further addressed the long-standing challenge of uncovering the fungal Taxol biosynthesis genes and pathway. In genome-wide sequence analysis, among 13,249 predicted gene models, 8 associated with the mevalonate pathway and 19 other Taxol biosynthesis genes were determined, whereas no single 2-C-methyl-D-erythritol 4-phosphate pathway-related gene was found. The identified fungal Taxol biosynthesis genes are mainly homologous to those in <i>Taxus</i> and other plant species, with low percentage identities. Contrary to past studies, the conserved \"DXDD\" motif was observed in predicted taxa-4(5),11(12)-diene synthase of <i>F. tricinctum</i> and <i>Pestalotiopsis microspora.</i> Notably, despite the low sequence identities between <i>F. tricinctum</i> and <i>Taxus brevifolia</i> taxa-4(5),11(12)-diene synthase, the remarkable structural similarity of their active sites indicates likely conservation of enzymatic function. The study revealed the Taxol production and sole involvement of the mevalonate pathway in the biosynthesis of Taxol precursors, while supporting the potential independent origin of the Taxol biosynthesis pathway in <i>F. tricinctum</i> from the host plants. This work also provides an understanding of Taxol biosynthesis and establishes a foundation for its biotechnological production.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04657-z.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"39"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145861763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Soybean plants showing the symptoms of veinal necrosis and bud blight were examined to identify the associated viral agent. Transmission electron microscopy revealed the flexuous and filamentous virus particles. DAC-ELISA of symptomatic samples confirmed the presence of cowpea mild mottle virus (CPMMV) while other tested viruses GBNV, SMV, SVNV, TSV and TRSV were found to be absent. RT-PCR using CPMMV coat protein (CP) gene primers consistently produced an 867-bp amplicon, whereas amplification was not observed for other viruses confirming its association with the disease. Sequence analysis of the CPMMV CP gene showed 99% similarity with Indian urdbean isolate (MH345698) followed by other CPMMV isolates (89-98%) and clustered phylogenetically distinct from Brazil, China and Ghana isolates. Mechanical sap inoculation resulted in 30-60% transmission efficiency across host species. Nicotiana benthamiana exhibited severe systemic infection and seedling wilting, indicating high susceptibility. Cowpea and French bean developed systemic chlorosis and necrosis, while soybean genotypes showed restricted symptoms. DAC-ELISA, RT-PCR and RT-qPCR confirmed CPMMV infection, with viral copy numbers ranging from 8.54 × 10⁵ to 5.7 × 10⁸ in field-collected soybean and 4.7 × 10⁸ in N. benthamiana. Cowpea and French bean accumulated moderate viral loads, whereas soybean genotypes Pusa-12 and PS-1670 supported limited replication. No other viruses were detected. These results conclusively establish CPMMV as the causal agent of veinal necrosis and bud blight disease in soybean and demonstrate its differential infectivity and accumulation across host species.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04640-8.
{"title":"<i>Cowpea mild mottle virus</i> (<i>Carlavirus vignae</i>) identified as one of the agents associated with veinal necrosis and bud blight disease in soybean (<i>Glycine max</i> L.) in India.","authors":"Nagamani Sandra, Ankita Tripathi, Dhruva Nitin Bhagwatkar, Garima Dalal, Sharankumar Kesaratagi, Manisha Saini, Sanjay Kumar Lal","doi":"10.1007/s13205-025-04640-8","DOIUrl":"https://doi.org/10.1007/s13205-025-04640-8","url":null,"abstract":"<p><p>Soybean plants showing the symptoms of veinal necrosis and bud blight were examined to identify the associated viral agent. Transmission electron microscopy revealed the flexuous and filamentous virus particles. DAC-ELISA of symptomatic samples confirmed the presence of cowpea mild mottle virus (CPMMV) while other tested viruses GBNV, SMV, SVNV, TSV and TRSV were found to be absent. RT-PCR using CPMMV coat protein (CP) gene primers consistently produced an 867-bp amplicon, whereas amplification was not observed for other viruses confirming its association with the disease. Sequence analysis of the CPMMV CP gene showed 99% similarity with Indian urdbean isolate (MH345698) followed by other CPMMV isolates (89-98%) and clustered phylogenetically distinct from Brazil, China and Ghana isolates. Mechanical sap inoculation resulted in 30-60% transmission efficiency across host species. <i>Nicotiana benthamiana</i> exhibited severe systemic infection and seedling wilting, indicating high susceptibility. Cowpea and French bean developed systemic chlorosis and necrosis, while soybean genotypes showed restricted symptoms. DAC-ELISA, RT-PCR and RT-qPCR confirmed CPMMV infection, with viral copy numbers ranging from 8.54 × 10⁵ to 5.7 × 10⁸ in field-collected soybean and 4.7 × 10⁸ in <i>N. benthamiana</i>. Cowpea and French bean accumulated moderate viral loads, whereas soybean genotypes Pusa-12 and PS-1670 supported limited replication. No other viruses were detected. These results conclusively establish CPMMV as the causal agent of veinal necrosis and bud blight disease in soybean and demonstrate its differential infectivity and accumulation across host species.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04640-8.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"43"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The aging process is associated with gradual cognitive decline resulting from deficits in synaptic plasticity, the brain's natural ability to adapt and reshape its neural circuitry. This review highlights the importance of synaptic plasticity in cognitive function. It provides a full overview of the molecular, cellular, and systemic mechanisms involved in enhanced or diminished synaptic plasticity in the aging brain. We also go over issues in neurotransmitter systems, calcium signaling, neurotrophic support (ex., BDNF-TrkB), cellular signaling pathways (e.g. mTOR, CaMK, CREB, and MAPK/ERK), and neuroinflammation, oxidative stress, and vascular integrity, all of which redirect the trajectory of synaptic failure associated with cognitive decline in aging. Therapeutic approaches toward increasing or restoring synaptic plasticity are evaluated, including pharmacological (e.g., nootropics, cholinesterase inhibitors, NMDA receptor modulators), natural (e.g., curcumin, resveratrol, bacoside A), and new interventions (e.g., psychoplastogens, gene therapy, nanocarriers, and digital therapeutics). Lifestyle approaches, especially physical exercise, cognitive training, intermittent fasting, and mindfulness approaches to stimulation, have highly potent effects on plasticity enhancements and employ multiple neurobiological mechanisms. Despite much promise, there remain substantial translational challenges, including limited clinical efficacy, lack of personalized biomarkers, and ethical considerations concerning cognitive enhancement. As we look ahead, a multidisciplinary integrative approach that includes molecular therapeutics, lifestyle interventions, and next-generation neurotechnologies will be most useful for protecting cognitive health and enhancing brain resilience in aging individuals. This review highlights the immediate necessity for personalized, ethical, and evidence-based approaches to take advantage of synaptic plasticity for healthy cognitive aging.
{"title":"Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging.","authors":"Falguni Goel, Payal Singh, Sachchida Nand Rai, Dharmendra Kumar Yadav","doi":"10.1007/s13205-025-04673-z","DOIUrl":"https://doi.org/10.1007/s13205-025-04673-z","url":null,"abstract":"<p><p>The aging process is associated with gradual cognitive decline resulting from deficits in synaptic plasticity, the brain's natural ability to adapt and reshape its neural circuitry. This review highlights the importance of synaptic plasticity in cognitive function. It provides a full overview of the molecular, cellular, and systemic mechanisms involved in enhanced or diminished synaptic plasticity in the aging brain. We also go over issues in neurotransmitter systems, calcium signaling, neurotrophic support (ex., BDNF-TrkB), cellular signaling pathways (e.g. mTOR, CaMK, CREB, and MAPK/ERK), and neuroinflammation, oxidative stress, and vascular integrity, all of which redirect the trajectory of synaptic failure associated with cognitive decline in aging. Therapeutic approaches toward increasing or restoring synaptic plasticity are evaluated, including pharmacological (e.g., nootropics, cholinesterase inhibitors, NMDA receptor modulators), natural (e.g., curcumin, resveratrol, bacoside A), and new interventions (e.g., psychoplastogens, gene therapy, nanocarriers, and digital therapeutics). Lifestyle approaches, especially physical exercise, cognitive training, intermittent fasting, and mindfulness approaches to stimulation, have highly potent effects on plasticity enhancements and employ multiple neurobiological mechanisms. Despite much promise, there remain substantial translational challenges, including limited clinical efficacy, lack of personalized biomarkers, and ethical considerations concerning cognitive enhancement. As we look ahead, a multidisciplinary integrative approach that includes molecular therapeutics, lifestyle interventions, and next-generation neurotechnologies will be most useful for protecting cognitive health and enhancing brain resilience in aging individuals. This review highlights the immediate necessity for personalized, ethical, and evidence-based approaches to take advantage of synaptic plasticity for healthy cognitive aging.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"64"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-08DOI: 10.1007/s13205-025-04637-3
Sushil Kumar, Amar A Sakure, Hensi Kundaria, Mukesh P Patel, Rumit Patel, Pankaj Katba, Kaplesh Patel
Castor (Ricinus communis L.) in Euphorbiaceae family is an important tropical crop cultivated for seeds containing industrially valuable oil. With economic development, demand for castor beans and oil is rapidly increasing, yet production is severely affected by fungal diseases, particularly Fusarium and Macrophomina, due to limited advanced breeding methods. F. oxysporum f. sp. ricini -induced wilt in castor is a major pathogenic factor responsible for severe yield losses. Wilt resistance, a complex trait controlled by quantitative trait loci (QTLs), was investigated in this study by developing a linkage map and identifying novel QTLs in castor using F2:3 population. The was developed from the cross between two castor inbred lines, 48 - 1 (Jwala) and the wilt-susceptible genotype JI-35, and screened under pot conditions. Linkage map was developed using 71 SSR markers. A genetic map comprising 13 linkage groups, spanning a total of 1,028.7 cM centimorgans (cM). Analysis of genotypic and phenotypic data from the mapping population, evaluated for wilt in pots, identified two QTLs on LG1 and 6 explaining 12.44-16.58% of phenotypic variation. PCR amplification using linked markers on LG 1 in resistant and susceptible F₄ families of the mapping population demonstrated that these markers effectively distinguish plants resistant or susceptible to wilt disease. These markers can be utilized for developing resistant varieties via backcross breeding and for screening germplasm at the seedling stage.
蓖麻(Ricinus communis L.)是大戟科的一种重要的热带作物,其种子含有工业价值油。随着经济的发展,对蓖麻豆和蓖麻油的需求迅速增加,但由于先进的育种方法有限,生产受到真菌病害的严重影响,特别是镰刀菌和巨镰刀菌。蓖麻枯萎病是造成蓖麻产量严重损失的主要致病因素。本研究以蓖麻F2:3群体为研究对象,建立了蓖麻抗黄萎病的连锁图谱,并鉴定了新的qtl。以蓖麻48 - 1 (Jwala)和JI-35为亲本,在盆栽条件下进行筛选。利用71个SSR标记构建连锁图谱。由13个连锁群组成的遗传图谱,共跨越1028.7 cM cM。对定位群体的基因型和表型数据进行分析,鉴定出LG1和lg6上的两个qtl,解释了12.44-16.58%的表型变异。利用f4抗性和易感家族的LG 1连锁标记进行PCR扩增,结果表明这些标记可以有效区分植物对枯萎病的抗性和易感性。这些标记可用于回交选育抗性品种和苗期种质筛选。
{"title":"Development of linkage map and mapping of SSR markers linked to fusarium wilt resistance in F<sub>2:3</sub> population of castor (<i>Ricinus communis</i> L.).","authors":"Sushil Kumar, Amar A Sakure, Hensi Kundaria, Mukesh P Patel, Rumit Patel, Pankaj Katba, Kaplesh Patel","doi":"10.1007/s13205-025-04637-3","DOIUrl":"https://doi.org/10.1007/s13205-025-04637-3","url":null,"abstract":"<p><p>Castor (<i>Ricinus communis</i> L.) in Euphorbiaceae family is an important tropical crop cultivated for seeds containing industrially valuable oil. With economic development, demand for castor beans and oil is rapidly increasing, yet production is severely affected by fungal diseases, particularly <i>Fusarium</i> and <i>Macrophomina</i>, due to limited advanced breeding methods. <i>F. oxysporum</i> f. sp. <i>ricini</i> -induced wilt in castor is a major pathogenic factor responsible for severe yield losses. Wilt resistance, a complex trait controlled by quantitative trait loci (QTLs), was investigated in this study by developing a linkage map and identifying novel QTLs in castor using F2:3 population. The was developed from the cross between two castor inbred lines, 48 - 1 (Jwala) and the wilt-susceptible genotype JI-35, and screened under pot conditions. Linkage map was developed using 71 SSR markers. A genetic map comprising 13 linkage groups, spanning a total of 1,028.7 cM centimorgans (cM). Analysis of genotypic and phenotypic data from the mapping population, evaluated for wilt in pots, identified two QTLs on LG1 and 6 explaining 12.44-16.58% of phenotypic variation. PCR amplification using linked markers on LG 1 in resistant and susceptible F₄ families of the mapping population demonstrated that these markers effectively distinguish plants resistant or susceptible to wilt disease. These markers can be utilized for developing resistant varieties via backcross breeding and for screening germplasm at the seedling stage.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"25"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12686244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}